Articles mentioning Alkermes, Inc. (ALKS)

Results 1 - 10 of 47 : 1 2 3 4 5 Next

Get RSS Feed for ALKS

Investing | February 06, 2012

Alkermes Beats Up on Analysts Yet Again

Just the facts, Fool.

Investing | January 26, 2012

Will Bydureon Gain FDA Approval?

Get out your crystal ball.

High-Growth Investing | December 31, 2011

3 Stock-Moving Binary Events to Watch in 2012

A look at what's coming up in biotech.

High-Growth Investing | November 09, 2011

Byetta Breakup! Buying Opportunity?

We all saw this coming.

General Retirement | October 10, 2011

4-Star Stocks Poised to Pop: Alkermes

Market-trouncing returns could be written in this four-star.

Investing | July 08, 2011

Let's Just Hope For No More FDA Surprises

Despite the government's worries, Bydureon doesn't cause heart issues.

Investing | July 08, 2011

Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial

What does this mean for the drug companies?

High-Growth Investing | May 09, 2011

In Biotech, Two Platforms Are Better Than One

Alkermes buys Elan Drug Technology.

High-Growth Investing | April 15, 2011

Fewer Needle Pricks for the Europeans

Bydureon gets a positive recommendation in Europe.

Investing | April 15, 2011

Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug

Will this drug be approved in Europe?

Results 1 - 10 of 47 : 1 2 3 4 5 Next

Get RSS Feed for ALKS


Advertisement